GSK’s asthma blockbuster Nucala secures win in COPD Phase III trial
GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
What's Your Reaction?
